Logo of The Journal of Bone & Joint Surgery (Br)
Quick search:        
          Advanced Search
Guest Access | Sign In
Journal of Bone and Joint Surgery - British Volume, Vol 85-B, Issue 1, 107-114.
doi: 10.1302/0301-620X.85B1.12781  
Copyright © 2003 by British Editorial Society of Bone and Joint Surgery
This Article
Right arrow Full Text (PDF)
Right arrow Japanese
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bacci, G.
Right arrow Articles by Barbieri, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bacci, G.
Right arrow Articles by Barbieri, E.

Local and systemic control in Ewing’s sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery

G. Bacci, MD; S. Ferrari, MD; A. Longhi, MD; M. Versari, MA; C. Forni, RN; and D. Donati, MD

Department of Chemotherapy

M. Manfrini, MD; and P. Trentani, MD

5th Department of Orthopaedic Surgery Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy.

E. Barbieri, MD

Department of Radiotherapy, Policlinico S. Orsola, Bologna, Italy.

Correspondence should be sent to Dr G. Bacci.

The role of radiotherapy and/or surgery in the local treatment of Ewing’s sarcoma has still to be determined. The outcome of Ewing’s sarcoma may differ according to its location and a selection bias towards surgery limits the ability to compare methods of local treatment. We have carried out a retrospective review of 91 consecutive patients treated for non-metastatic Ewing’s sarcoma of the femur. They received chemotherapy according to four different protocols. The primary lesion was treated by surgery alone (54 patients), surgery and radiotherapy (13) and radiotherapy alone (23). One was treated by chemotherapy alone.

At a median follow-up of ten years, 48 patients (53%) remain free from disease, 39 (43%) have relapsed, two (2%) have died from chemotherapeutic toxicity and two (2%) have developed a radio-induced second tumour.

The probability of survival without local recurrence was significantly (p = 0.01) higher in patients who were treated by surgery with or without radiotherapy (88%) than for patients who received radiotherapy alone (59%). The five- and ten-year overall survival rates were 64% and 57%, respectively. Patients who were treated by surgery, with or without radiotherapy, had a five- and ten-year overall survival of 64%. Patients who received only radiotherapy had a five- and ten-year survival of 57% and 44%, respectively.

Our results indicate that in patients with Ewing’s sarcoma of the femur, better local control is achieved by surgical treatment (with or without radiotherapy) compared with the use of radiotherapy alone. Further studies are needed to verify the impact of this strategy on overall survival.




This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
J. S. Weisstein, R. E. Goldsby, and R. J. O'Donnell
Oncologic Approaches to Pediatric Limb Preservation
J. Am. Acad. Ortho. Surg., December 1, 2005; 13(8): 544 - 554.
[Abstract] [Full Text] [PDF]



(c) British Editorial Society of Bone and Joint Surgery All Rights Reserved
Registered charity no: 209299     Print ISSN: 0301-620X
Hip, Knee, Trauma, Upper limb, Foot & Ankle, Paediatrics, Oncology, Spine, Arthroplasty, General